Three New Drugs Approved for Type 2 Diabetes

powered by healthline

Average Ratings

All contain new active ingredient aimed at improving glucose control

MONDAY, Jan. 28 (HealthDay News) -- Three new related drugs designed to improve blood sugar control in people with type 2 diabetes have been approved by the U.S. Food and Drug Administration.

All three drugs contain a new active ingredient, alogliptin (brand named Nesina), either by itself or with other previously approved medications. In addition to Nesina, the agency approved Kazano (alogliptin and metformin hydrocholoride) and Oseni (alogliptin and pioglitazone).

Type 2 diabetes leads the body to resist insulin or to produce insufficient amounts of the hormone, causing blood sugar to spike. The disease affects about 24 million people in the United States, accounting for more than 90 percent of diabetes cases, the FDA said in a news release.

Nesina, either by itself or in combination with other medications, was tested in 14 clinical studies involving some 8,500 people with type 2 diabetes. The new drugs should not be used by people with type 1 diabetes, or by people who have high amounts of ketones in the blood or urine, the FDA said.

The most common side effects of alogliptin included runny nose, headache and upper respiratory tract infection. Additional adverse reactions were reported among people who used the combination medications.

Kazano's label will include a "black box" warning of the possibility of lactic acidosis, a buildup of lactic acid in the blood.

All of the new medications are distributed by Takeda Pharmaceuticals America, based in Deerfield, Ill.

More information

The FDA has more about this approval.


-- Scott Roberts
Health News Copyright © 2013 HealthDay. All rights reserved.
Article from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.